FY22 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The US Food and Drug Administration is seeking basic and applied research and development proposals to support regulatory science and innovation through a Broad Agency Announcement. This effort aims to advance scientific knowledge in specific research areas to help the FDA fulfill its mission of protecting and promoting national health. The current contract, held by the Massachusetts Institute of Technology with a value of 82,182,000 dollars, is expected to end on September 28, 2026. This opportunity is classified as a high-confidence full recompete and will be conducted under full and open competition with firm fixed price pricing. The solicitation is managed by the FDA Office of Acquisition and Grant Services under NAICS code 541720. This announcement serves as an annual renewal of previous efforts and remains open until further notice for the acquisition of advanced research and development.
General Info
Place of Performance
Silver Spring, MD, 20993, USASet-Aside
Documents
0AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Current Contract: 75F40122C00200 Incumbent: MASSACHUSETTS INSTITUTE OF TECHNOLOGY Contract Value: $82,182,000 Potential End Date: 2026-09-28T00:00:00.000Z Competition: FULL AND OPEN COMPETITION Pricing: FIRM FIXED PRICE Classification: full-recompete (Confidence: high - 90/100)
In accordance with FAR 6.102(d)(2) and 35.016, the US Food and Drug Administration (FDA) solicits for the acquisition of basic and applied research and development proposals to support regulatory science and innovation through this Broad Agency Announcement (BAA). Research and development activities acquired under this BAA are intended to advance scientific knowledge in specific research areas as well as sub areas of interest defined within the BAA that serve the FDA in accomplishing its mission to protect and promote the health of our nation. Proposals submitted under this announcement are not limited solely to the PSC code "AJ11" specified in this announcement. *This announcement is a renewal of the prior-year FY21 announcement (FDABAA-21-00123) and will remain open until further notice. This announcement is renewed on an annual basis.
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
